Curebound, a philanthropic organization that funds innovative cancer research and accelerates better prevention, detection, and treatments for cancer, today announced the appointment of Gil Alvarado, ...

As Neurocrine enters 2026, our foundation is stronger than at any point in our more than 30-year history and it continues to strengthen, with growing enterprise-wide momentum and strategic and ...

New board leadership brings expanded expertise to support MODS’ role as a regional leader in STEM education, play-based ...